CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 97 filers reported holding CYTOKINETICS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,806,566 | +208.9% | 298,933 | +11.2% | 1.60% | +582.6% |
| Q4 2019 | $2,851,000 | +66.5% | 268,747 | +28.0% | 0.24% | +16.9% |
| Q4 2017 | $1,712,000 | -64.0% | 210,000 | -36.0% | 0.20% | -70.4% |
| Q3 2017 | $4,756,000 | +80.3% | 327,990 | +50.5% | 0.68% | +51.6% |
| Q2 2017 | $2,638,000 | +34.9% | 217,990 | +43.2% | 0.45% | +17.3% |
| Q1 2017 | $1,956,000 | +543.4% | 152,200 | +374.6% | 0.38% | +383.5% |
| Q2 2016 | $304,000 | -87.4% | 32,069 | -90.6% | 0.08% | -84.9% |
| Q1 2016 | $2,411,000 | -3.2% | 341,944 | -8.1% | 0.52% | +64.5% |
| Q3 2015 | $2,490,000 | -12.3% | 372,250 | -11.8% | 0.32% | +14.4% |
| Q2 2015 | $2,838,000 | -28.2% | 422,250 | -14.4% | 0.28% | -58.7% |
| Q4 2014 | $3,951,000 | +208.9% | 493,212 | +35.8% | 0.67% | +325.9% |
| Q3 2014 | $1,279,000 | +311.3% | 363,212 | +457.9% | 0.16% | +105.2% |
| Q2 2014 | $311,000 | -74.8% | 65,100 | -49.9% | 0.08% | -72.7% |
| Q1 2014 | $1,235,000 | +13.7% | 130,000 | -22.2% | 0.28% | -6.6% |
| Q4 2013 | $1,086,000 | – | 167,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |